AU5104100A - Method for judging rheumatoid arthritis - Google Patents

Method for judging rheumatoid arthritis

Info

Publication number
AU5104100A
AU5104100A AU51041/00A AU5104100A AU5104100A AU 5104100 A AU5104100 A AU 5104100A AU 51041/00 A AU51041/00 A AU 51041/00A AU 5104100 A AU5104100 A AU 5104100A AU 5104100 A AU5104100 A AU 5104100A
Authority
AU
Australia
Prior art keywords
judging
rheumatoid arthritis
rheumatoid
arthritis
judging rheumatoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51041/00A
Inventor
Tetsuyoshi Ishiwata
Tatsunari Nishi
Katsutoshi Sasaki
Shigemasa Sawada
Masami Takei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU5104100A publication Critical patent/AU5104100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51041/00A 1999-06-02 2000-06-01 Method for judging rheumatoid arthritis Abandoned AU5104100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15462599 1999-06-02
JP11/154625 1999-06-02
PCT/JP2000/003552 WO2000075313A1 (en) 1999-06-02 2000-06-01 Method for judging rheumatoid arthritis

Publications (1)

Publication Number Publication Date
AU5104100A true AU5104100A (en) 2000-12-28

Family

ID=15588286

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51041/00A Abandoned AU5104100A (en) 1999-06-02 2000-06-01 Method for judging rheumatoid arthritis

Country Status (3)

Country Link
JP (1) JP4542732B2 (en)
AU (1) AU5104100A (en)
WO (1) WO2000075313A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006008183A1 (en) * 2004-07-23 2006-01-26 Novartis Ag Biomarkers for rheumatoid arthritis (ra)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
JP2726500B2 (en) * 1989-07-14 1998-03-11 学校法人藤田学園 Agalactosyl IgG and diagnostics
JPH0587814A (en) * 1991-09-30 1993-04-06 Konica Corp Method and medicine for rheumatism diagnosis and determination method for agalactosill igg
CN1214735A (en) * 1996-12-05 1999-04-21 协和发酵工业株式会社 IgA nephropathy-associated gene
WO1999026980A1 (en) * 1997-11-21 1999-06-03 Beth Israel Deaconess Medical Center Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators

Also Published As

Publication number Publication date
WO2000075313A1 (en) 2000-12-14
JP4542732B2 (en) 2010-09-15

Similar Documents

Publication Publication Date Title
AU777213C (en) Blasting method
AU5304299A (en) Method for modifying chromosomes
AU3035299A (en) Method for powder-coating
AU1882901A (en) Pointing method
AU3073400A (en) Method for producing chlorine
AU1854901A (en) Novel method
AU4704699A (en) Method for inverting packages
AU6237900A (en) System and method for inspecting cans
AU2308900A (en) Analysis method
AU1553101A (en) Screening method
AU6580200A (en) Genetic marker for rheumatoid arthritis
AU6429000A (en) Screening method
AU3439301A (en) Method for preventing diarrhea
AU7432700A (en) Separation method
AU5104100A (en) Method for judging rheumatoid arthritis
AU6825500A (en) Method for detecting microorganisms
AU2872501A (en) Screening method
AU1850501A (en) Method for determining that a product has been organically produced
AU7121000A (en) Method for parallel polymerization
AU1283001A (en) Method for producing alkylhalogenosilanes
AU5552200A (en) Method
AU3789100A (en) Method for utilizing waste
AU1807100A (en) Flotation system and method for off-shore platform
AU1141501A (en) Method for producing hydroxymethylpyridines
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase